SINO BIOPHARMACEUTICAL earnings per share and revenue

1177 earnings per share for the last semiannual are 0.08 HKD whereas the estimation was 0.08 HKD which accounts for 9.43% surprise. Company revenue for the same period amounts to 17.06 B HKD despite the estimated figure of 16.28 B HKD. Estimated earnings per share for the next semiannual are 0.07 HKD, and revenue is expected to reach 16.30 B HKD. Also watch annual changes over time to get a bigger picture of 1177 earnings per share and revenue dynamics.